跳至主要内容
临床试验/ACTRN12613000526774
ACTRN12613000526774尚未招募1 期

Among patients with arrhythmia in which the mechanism or sequence of electrical activation is not readily diagnosed by standard 12-lead electrocardiogram (ECG), is Torso Surface Electrical Mapping more useful than ECG in arrhythmia mechanism and guiding treatment strategy.

Bioengineering Institute, University of Auckland0 个研究点目标入组 50 人开始时间: 2013年5月13日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 100 Years(—)
性别
All

入选标准

  • Patients undergoing electrophysiological study for arrhythmia, the mechanism of which is not easily diagnosed by 12-lead ECG. Participants must have a clinical requirement for CT scan of the chest.

排除标准

  • Exclusion criteria of the study are: age <15yrs, inability to provide informed consent, pregnancy, limited mobility or inability to lie flat for 20 minutes, previous severe skin reaction to ECG electrodes, fragile skin likely to result in skin tear, and an eGFR of less than or equal to 30ml/min

研究者

发起方
Bioengineering Institute, University of Auckland

相似试验